Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease

Monte S Willis1, Jonathan C Schisler, Cam Patterson

  • 1Department of Pathology & Laboratory Medicine, Carolina Cardiovascular Biology Center, 2340B Medical Biomolecular Research Building, University of North Carolina, Chapel Hill, NC 27599-7525, USA.

Future Cardiology
|June 23, 2009
PubMed

Insights

The ubiquitin-proteasome system (UPS) maintains heart health by degrading proteins. Targeting specific UPS components, like E3 ubiquitin ligases, may offer safer cardiac disease therapies than broad proteasome inhibition.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Protein Degradation

Background:

  • The heart requires constant protein quality control, managed by the ubiquitin-proteasome system (UPS).
  • The UPS plays a specific role in cardiac hypertrophy, ischemic heart disease, and cardiomyopathies.
  • Proteasome inhibitors show therapeutic potential in animal models but can be cardiotoxic in humans.

Purpose of the Study:

  • To review the function of the UPS in cardiac disease.
  • To explore the therapeutic potential of targeting specific UPS components for cardiac conditions.

Main Methods:

  • Literature review of studies on the ubiquitin-proteasome system in cardiac disease.
  • Analysis of research on proteasome inhibitors and E3 ubiquitin ligases in cardiovascular contexts.

Main Results:

  • The UPS is crucial for maintaining cardiac protein homeostasis.
  • Specific UPS components are implicated in various cardiac pathologies.
  • Targeting E3 ubiquitin ligases presents a promising therapeutic avenue for cardiac diseases.

Conclusions:

  • The UPS is a key regulator in cardiac health and disease.
  • Targeting specific E3 ubiquitin ligases offers a potential strategy for novel cardiac therapies.
  • Further research into UPS regulation is needed for effective cardiovascular treatments.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...